Search
Search Results
##search.searchResults.foundPlural##
-
THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies
1325PDF: 472HTML: 221 -
INVASIVE FUNGAL INFECTION IN CHILDREN WITH ACUTE LEUKEMIA AND SEVERE APLASTIC ANEMIA IFI in Children with Acute Leukemia and SAA
2372PDF: 631HTML: 182 -
-
Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
2615PDF: 904HTML: 3092flowcytometric result of peripheral blood sample: 142 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2333PDF: 730HTML: 1710 -
MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
2618PDF: 1015HTML: 3240 -
Pseudo-differentiation syndrome
1221PDF: 607HTML: 10822Figure 1: peripheral blood showing myeloblasts with auer rods: 98Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 84Figure 3: CXR showing pulmonary infiltartes with consolidation: 106Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 83Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 103 -
Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated Acute Myeloid leukemia- A case report and review of literature
1738PDF: 831HTML: 1731Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated AML- IMAGES: 129 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2634PDF: 784HTML: 6479Untitled: 184Untitled: 151Untitled: 154Untitled: 161 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2585PDF: 1689HTML: 3598Pellagatti Fig 1: 165Pellagatti Fig. 2: 174 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1528PDF: 870HTML: 123 -
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
853PDF: 455HTML: 145 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1448PDF: 754HTML: 132 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1087PDF: 685HTML: 1311Figure 1: 147Figure 2: 138 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
601PDF: 747PDF Supp. Files: 63HTML: 164 -
How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency
1731PDF: 841HTML: 918Referring article: 704 -
ANORECTAL PATHOLOGIES IN THE COURSE OF ACUTE LEUKAEMIAS: PREDICTIVE PARAMETERS Anorectal pathologies in leukemias
1075PDF: 631Html: 70 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
1874PDF: 710HTML: 3092 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3398PDF: 1410HTML: 4145CoverLetter: 157Figure1: 161 -
HOW I TREAT NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA
13099PDF: 909HTML: 7260 -
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
827PDF: 1155HTML: 82







